Qorvo® Announces Fiscal 2022 First Quarter Financial Results Read more about Qorvo® Announces Fiscal 2022 First Quarter Financial Results
Qorvo® to Webcast Quarterly Earnings Conference Call on August 4, 2021 Read more about Qorvo® to Webcast Quarterly Earnings Conference Call on August 4, 2021
Qorvo® to Present at the Bank of America Securities 2021 Global Technology Conference Read more about Qorvo® to Present at the Bank of America Securities 2021 Global Technology Conference
Qorvo® to Present at the J.P. Morgan Global Technology, Media and Communications Conference Read more about Qorvo® to Present at the J.P. Morgan Global Technology, Media and Communications Conference
Qorvo® Appoints Judy Bruner to its Board of Directors Read more about Qorvo® Appoints Judy Bruner to its Board of Directors
Qorvo® Acquires Leading MEMS-based Sensor Solution Provider NextInput Read more about Qorvo® Acquires Leading MEMS-based Sensor Solution Provider NextInput
Qorvo® Announces Fiscal 2021 Fourth Quarter Financial Results Read more about Qorvo® Announces Fiscal 2021 Fourth Quarter Financial Results
Qorvo® to Webcast Quarterly Earnings Conference Call on May 5, 2021 Read more about Qorvo® to Webcast Quarterly Earnings Conference Call on May 5, 2021
Qorvo Biotechnologies Awarded $24.4 Million National Institutes of Health Contract to Scale Point-of-Care COVID-19 Antigen Testing Read more about Qorvo Biotechnologies Awarded $24.4 Million National Institutes of Health Contract to Scale Point-of-Care COVID-19 Antigen Testing
Qorvo® Biotechnologies Receives FDA Emergency Use Authorization (EUA) for Rapid COVID-19 Antigen Testing Read more about Qorvo® Biotechnologies Receives FDA Emergency Use Authorization (EUA) for Rapid COVID-19 Antigen Testing
